The Pharma Data

MAY 13, 2021

Testimonials are not necessarily representative of all of those who will use our products. Some of our testimonials are provided by customers who have received promotional offers in exchange for their participation. The testimonials displayed are given verbatim except for correction of grammatical or typing errors. Pediatr Ann.

Disease 52

Disease Production Testimonials Science 52

Agency IQ

OCTOBER 20, 2023

Data from the 2012, 2016, and 2020 CDR and 1998, 2002, and 2006 Inventory Update Reporting (IUR) Rule are included in the PFAS Analytic Tools. While there are a variety of reporting thresholds, sites manufacturing or importing 25,000 pounds or more of a chemical substance in a given year are required to report to CDR.

Regulations 40

Regulations Production Packaging Treatment 40

Agency IQ

JULY 28, 2023

DSCSA implementation – Down to the wire as a deadline draws near: The Drug Supply Chain Security Act (DSCSA) was enacted in 2013 as part of the Drug Quality and Security Act (DQSA), following several drug counterfeiting scandals in which falsified medical products entered the supply chain.

FDA 40

FDA Science Biosimilars Regulations 40

Codon

JUNE 2, 2024

Without mouse models, we may never have developed polio and meningitis vaccines, organ transplants, GLP-1 drugs, gene therapies , or any other number of transformative treatments. Adapted from Yoshiki and Moriwaki (2006). In a testimony in front of the U.S. Origins of mice used in research. Image Credit: JAX Handbook.

Laboratories 117

Laboratories Research Disease Science 117

Agency IQ

JULY 13, 2023

BY LAURA DIANGELO, MPH JUL 12, 2023 7:14 PM CDT Quick background: the Pandemic and All-Hazards Preparedness Act The Pandemic and All-Hazards Preparedness Act (PAHPA) was originally passed in 2006. Republicans have also indicated that legislation focused on drug shortages is proceeding separately.

FDA 40

FDA Packaging Laboratories Testimonials 40

Drug & Device Law

JANUARY 15, 2024

2d 888 (1996) (manufacturer immune from strict liability defective design claim premised upon sale of prescription drugs without adequate warning). Thus (unless and until the Dormant Commerce Clause puts a stop to it) any plaintiff anywhere in the country can sue Pennsylvania-registered drug or device manufacturers in Pennsylvania courts.

Compliance 52

Compliance Government FDA Compliance Production 52

Drug & Device Law

APRIL 29, 2022

We write on a chilly day in Philadelphia – we and the Drug and Device Law Little Rescue Dogs all shivered on our morning walk. On appeal, the intermediate appellate court affirmed, holding that “[the geologist’s] testimony about the amount of asbestos released. 2d 1114 (2006). The trial court denied the motion. 2d 584, 857 N.E.2d

Testimonials 52

Testimonials International Production Doctors 52